Cargando…

Identification and Characterization of the Direct Interaction between Methotrexate (MTX) and High-Mobility Group Box 1 (HMGB1) Protein

BACKGROUND: Methotrexate (MTX) is an agent used in chemotherapy of tumors and autoimmune disease including rheumatoid arthritis (RA). In addition, MTX has some anti-inflammatory activity. Although dihydrofolate reductase (DHFR) is a well-known target for the anti-tumor effect of MTX, the mode of act...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuroiwa, Yuki, Takakusagi, Yoichi, Kusayanagi, Tomoe, Kuramochi, Kouji, Imai, Takahiko, Hirayama, Tomoko, Ito, Ichiaki, Yoshida, Michiteru, Sakaguchi, Kengo, Sugawara, Fumio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643934/
https://www.ncbi.nlm.nih.gov/pubmed/23658798
http://dx.doi.org/10.1371/journal.pone.0063073
_version_ 1782268400714645504
author Kuroiwa, Yuki
Takakusagi, Yoichi
Kusayanagi, Tomoe
Kuramochi, Kouji
Imai, Takahiko
Hirayama, Tomoko
Ito, Ichiaki
Yoshida, Michiteru
Sakaguchi, Kengo
Sugawara, Fumio
author_facet Kuroiwa, Yuki
Takakusagi, Yoichi
Kusayanagi, Tomoe
Kuramochi, Kouji
Imai, Takahiko
Hirayama, Tomoko
Ito, Ichiaki
Yoshida, Michiteru
Sakaguchi, Kengo
Sugawara, Fumio
author_sort Kuroiwa, Yuki
collection PubMed
description BACKGROUND: Methotrexate (MTX) is an agent used in chemotherapy of tumors and autoimmune disease including rheumatoid arthritis (RA). In addition, MTX has some anti-inflammatory activity. Although dihydrofolate reductase (DHFR) is a well-known target for the anti-tumor effect of MTX, the mode of action for the anti-inflammatory activity of MTX is not fully understood. METHODOLOGY/RESULT: Here, we performed a screening of MTX-binding proteins using T7 phage display with a synthetic biotinylated MTX derivative. We then characterized the interactions using surface plasmon resonance (SPR) analysis and electrophoretic mobility shift assay (EMSA). Using a T7 phage display screen, we identified T7 phages that displayed part of high-mobility group box 1 (HMGB1) protein (K86-V175). Binding affinities as well as likely binding sites were characterized using genetically engineered truncated versions of HMGB1 protein (Al G1-K87, Bj: F88-K181), indicating that MTX binds to HMGB1 via two independent sites with a dissociation constants (K(D)) of 0.50±0.03 µM for Al and 0.24±0.01 µM for Bj. Although MTX did not inhibit the binding of HMGB1 to DNA via these domains, HMGB1/RAGE association was impeded in the presence of MTX. These data suggested that binding of MTX to part of the RAGE-binding region (K149-V175) in HMGB1 might be significant for the anti-inflammatory effect of MTX. Indeed, in murine macrophage-like cells (RAW 264.7), TNF-α release and mitogenic activity elicited by specific RAGE stimulation with a truncated monomeric HMGB1 were inhibited in the presence of MTX. CONCLUSIONS/SIGNIFICANCE: These data demonstrate that HMGB1 is a direct binding protein of MTX. Moreover, binding of MTX to RAGE-binding region in HMGB1 inhibited the HMGB1/RAGE interaction at the molecular and cellular levels. These data might explain the molecular basis underlying the mechanism of action for the anti-inflammatory effect of MTX.
format Online
Article
Text
id pubmed-3643934
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-36439342013-05-08 Identification and Characterization of the Direct Interaction between Methotrexate (MTX) and High-Mobility Group Box 1 (HMGB1) Protein Kuroiwa, Yuki Takakusagi, Yoichi Kusayanagi, Tomoe Kuramochi, Kouji Imai, Takahiko Hirayama, Tomoko Ito, Ichiaki Yoshida, Michiteru Sakaguchi, Kengo Sugawara, Fumio PLoS One Research Article BACKGROUND: Methotrexate (MTX) is an agent used in chemotherapy of tumors and autoimmune disease including rheumatoid arthritis (RA). In addition, MTX has some anti-inflammatory activity. Although dihydrofolate reductase (DHFR) is a well-known target for the anti-tumor effect of MTX, the mode of action for the anti-inflammatory activity of MTX is not fully understood. METHODOLOGY/RESULT: Here, we performed a screening of MTX-binding proteins using T7 phage display with a synthetic biotinylated MTX derivative. We then characterized the interactions using surface plasmon resonance (SPR) analysis and electrophoretic mobility shift assay (EMSA). Using a T7 phage display screen, we identified T7 phages that displayed part of high-mobility group box 1 (HMGB1) protein (K86-V175). Binding affinities as well as likely binding sites were characterized using genetically engineered truncated versions of HMGB1 protein (Al G1-K87, Bj: F88-K181), indicating that MTX binds to HMGB1 via two independent sites with a dissociation constants (K(D)) of 0.50±0.03 µM for Al and 0.24±0.01 µM for Bj. Although MTX did not inhibit the binding of HMGB1 to DNA via these domains, HMGB1/RAGE association was impeded in the presence of MTX. These data suggested that binding of MTX to part of the RAGE-binding region (K149-V175) in HMGB1 might be significant for the anti-inflammatory effect of MTX. Indeed, in murine macrophage-like cells (RAW 264.7), TNF-α release and mitogenic activity elicited by specific RAGE stimulation with a truncated monomeric HMGB1 were inhibited in the presence of MTX. CONCLUSIONS/SIGNIFICANCE: These data demonstrate that HMGB1 is a direct binding protein of MTX. Moreover, binding of MTX to RAGE-binding region in HMGB1 inhibited the HMGB1/RAGE interaction at the molecular and cellular levels. These data might explain the molecular basis underlying the mechanism of action for the anti-inflammatory effect of MTX. Public Library of Science 2013-05-03 /pmc/articles/PMC3643934/ /pubmed/23658798 http://dx.doi.org/10.1371/journal.pone.0063073 Text en © 2013 Kuroiwa et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Kuroiwa, Yuki
Takakusagi, Yoichi
Kusayanagi, Tomoe
Kuramochi, Kouji
Imai, Takahiko
Hirayama, Tomoko
Ito, Ichiaki
Yoshida, Michiteru
Sakaguchi, Kengo
Sugawara, Fumio
Identification and Characterization of the Direct Interaction between Methotrexate (MTX) and High-Mobility Group Box 1 (HMGB1) Protein
title Identification and Characterization of the Direct Interaction between Methotrexate (MTX) and High-Mobility Group Box 1 (HMGB1) Protein
title_full Identification and Characterization of the Direct Interaction between Methotrexate (MTX) and High-Mobility Group Box 1 (HMGB1) Protein
title_fullStr Identification and Characterization of the Direct Interaction between Methotrexate (MTX) and High-Mobility Group Box 1 (HMGB1) Protein
title_full_unstemmed Identification and Characterization of the Direct Interaction between Methotrexate (MTX) and High-Mobility Group Box 1 (HMGB1) Protein
title_short Identification and Characterization of the Direct Interaction between Methotrexate (MTX) and High-Mobility Group Box 1 (HMGB1) Protein
title_sort identification and characterization of the direct interaction between methotrexate (mtx) and high-mobility group box 1 (hmgb1) protein
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643934/
https://www.ncbi.nlm.nih.gov/pubmed/23658798
http://dx.doi.org/10.1371/journal.pone.0063073
work_keys_str_mv AT kuroiwayuki identificationandcharacterizationofthedirectinteractionbetweenmethotrexatemtxandhighmobilitygroupbox1hmgb1protein
AT takakusagiyoichi identificationandcharacterizationofthedirectinteractionbetweenmethotrexatemtxandhighmobilitygroupbox1hmgb1protein
AT kusayanagitomoe identificationandcharacterizationofthedirectinteractionbetweenmethotrexatemtxandhighmobilitygroupbox1hmgb1protein
AT kuramochikouji identificationandcharacterizationofthedirectinteractionbetweenmethotrexatemtxandhighmobilitygroupbox1hmgb1protein
AT imaitakahiko identificationandcharacterizationofthedirectinteractionbetweenmethotrexatemtxandhighmobilitygroupbox1hmgb1protein
AT hirayamatomoko identificationandcharacterizationofthedirectinteractionbetweenmethotrexatemtxandhighmobilitygroupbox1hmgb1protein
AT itoichiaki identificationandcharacterizationofthedirectinteractionbetweenmethotrexatemtxandhighmobilitygroupbox1hmgb1protein
AT yoshidamichiteru identificationandcharacterizationofthedirectinteractionbetweenmethotrexatemtxandhighmobilitygroupbox1hmgb1protein
AT sakaguchikengo identificationandcharacterizationofthedirectinteractionbetweenmethotrexatemtxandhighmobilitygroupbox1hmgb1protein
AT sugawarafumio identificationandcharacterizationofthedirectinteractionbetweenmethotrexatemtxandhighmobilitygroupbox1hmgb1protein